Wunder A - Search Results

1

Efficacy and tolerability of an aminopterin-albumin conjugate in tumor-bearing rats.

Kremer P, Hartung G, Bauder-Wüst U, Schrenk HH, Wunder A, Heckl S, Zillmann U, Sinn H. Kremer P, et al. Among authors: wunder a. Anticancer Drugs. 2002 Jul;13(6):615-23. doi: 10.1097/00001813-200207000-00008. Anticancer Drugs. 2002. PMID: 12172507

2

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

Wunder A, Müller-Ladner U, Stelzer EH, Funk J, Neumann E, Stehle G, Pap T, Sinn H, Gay S, Fiehn C. Wunder A, et al. J Immunol. 2003 May 1;170(9):4793-801. doi: 10.4049/jimmunol.170.9.4793. J Immunol. 2003. PMID: 12707361

3

Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.

Stehle G, Wunder A, Schrenk HH, Hartung G, Heene DL, Sinn H. Stehle G, et al. Among authors: wunder a. Anticancer Drugs. 1999 Sep;10(8):785-90. Anticancer Drugs. 1999. PMID: 10573211

4

Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats.

Stehle G, Wunder A, Schrenk HH, Hartung G, Heene DL, Sinn H. Stehle G, et al. Among authors: wunder a. Anticancer Drugs. 1999 Apr;10(4):405-11. doi: 10.1097/00001813-199904000-00009. Anticancer Drugs. 1999. PMID: 10378676

5

Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats.

Stehle G, Wunder A, Sinn H, Schrenk HH, Schütt S, Frei E, Hartung G, Maier-Borst W, Heene DL. Stehle G, et al. Among authors: wunder a. Anticancer Drugs. 1997 Oct;8(9):835-44. doi: 10.1097/00001813-199710000-00004. Anticancer Drugs. 1997. PMID: 9402310

6

The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats.

Stehle G, Sinn H, Wunder A, Schrenk HH, Schütt S, Maier-Borst W, Heene DL. Stehle G, et al. Among authors: wunder a. Anticancer Drugs. 1997 Aug;8(7):677-85. Anticancer Drugs. 1997. PMID: 9311444

7

Laser-induced fluorescence detection of malignant gliomas using fluorescein-labeled serum albumin: experimental and preliminary clinical results.

Kremer P, Wunder A, Sinn H, Haase T, Rheinwald M, Zillmann U, Albert FK, Kunze S. Kremer P, et al. Among authors: wunder a. Neurol Res. 2000 Jul;22(5):481-9. doi: 10.1080/01616412.2000.11740705. Neurol Res. 2000. PMID: 10935221

8

Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo.

Fiehn C, Neumann E, Wunder A, Krienke S, Gay S, Müller-Ladner U. Fiehn C, et al. Among authors: wunder a. Ann Rheum Dis. 2004 Jul;63(7):884-6. doi: 10.1136/ard.2003.013748. Ann Rheum Dis. 2004. PMID: 15194591 Free PMC article.

9

Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma.

Wunder A, Stehle G, Schrenk HH, Hartung G, Heene DL, Maier-Borst W, Sinn H. Wunder A, et al. Int J Cancer. 1998 Jun 10;76(6):884-90. doi: 10.1002/(sici)1097-0215(19980610)76:6<884::aid-ijc19>3.0.co;2-2. Int J Cancer. 1998. PMID: 9626357

10

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.

Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W. Hartung G, et al. Among authors: wunder a. Clin Cancer Res. 1999 Apr;5(4):753-9. Clin Cancer Res. 1999. PMID: 10213209 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results